Chemotherapy options and new advances in malignant pleural mesothelioma.
about
Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agentsGene therapy of mesothelioma.Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids.Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesotheliomaGemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810)Future developments in the management of malignant pleural mesothelioma.Methotrexate and gemcitabine combination chemotherapy for the treatment of malignant pleural mesothelioma.Vinflunine: review of a new vinca alkaloid and its potential role in oncology.p53-induced apoptosis occurs in the absence of p14(ARF) in malignant pleural mesothelioma.Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM).Synergistic effect of non-transmissible Sendai virus vector encoding the c-myc suppressor FUSE-binding protein-interacting repressor plus cisplatin in the treatment of malignant pleural mesothelioma.Phase-contrast microscopy studies of early cisplatin-induced morphological changes of malignant mesothelioma cells and the correspondence to induced apoptosis.A seven-year disease-free survivor of malignant pleural mesothelioma treated with hyperthermia and chemotherapy: a case report.The clinicopathological characteristics with long-term outcomes in malignant mesothelioma.Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma.
P2860
Q28546911-1E9FA27D-622A-46A4-83F2-C9852846813EQ36210859-CE38E191-A713-40EC-8161-5E0ADA6EBBF2Q36741548-392A74A9-BADD-407F-9882-29DF0965F32AQ36822893-AC74177C-9AA9-4774-A0D5-962CF94F07D7Q37243005-F26EF8FF-6E9C-4C54-94A7-9D7179D62522Q37449036-BB7504A2-BB45-4D96-9908-FB7E309500DEQ37562633-1E490850-E511-400D-A681-93D8F85639EFQ37768280-A1EABEFB-94ED-4A13-A9DE-AB6EB2E95065Q38311193-77A1AAD3-5DCF-4F49-A090-5594382960B2Q38399051-05613B85-E2F2-46C6-A8AA-2C60ED5362F0Q39571286-B781F479-AA13-4392-AA96-7E59578704ABQ40014385-F3B1D8C3-6FBC-4D6E-921E-82E1F72E9F89Q42599445-C2F24808-4E5E-4092-864F-1CAF749F5CDCQ51114246-B83467EC-0C33-4E09-A5A4-65033347F93DQ52672900-570B193A-AD64-4F2C-AE8C-8072BBD70289
P2860
Chemotherapy options and new advances in malignant pleural mesothelioma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Chemotherapy options and new advances in malignant pleural mesothelioma.
@ast
Chemotherapy options and new advances in malignant pleural mesothelioma.
@en
type
label
Chemotherapy options and new advances in malignant pleural mesothelioma.
@ast
Chemotherapy options and new advances in malignant pleural mesothelioma.
@en
prefLabel
Chemotherapy options and new advances in malignant pleural mesothelioma.
@ast
Chemotherapy options and new advances in malignant pleural mesothelioma.
@en
P2860
P356
P1433
P1476
Chemotherapy options and new advances in malignant pleural mesothelioma.
@en
P2093
A Klabatsa
J P C Steele
P2860
P304
P356
10.1093/ANNONC/MDI094
P577
2005-01-27T00:00:00Z